STK11 (LKB1) missense somatic mutant isoforms promote tumor growth, motility and inflammation

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Somatic mutations are crucial for understanding cancer and developing personalized medicine.
• STK11 (LKB1) is frequently inactivated in human cancers, but the roles of its somatic missense mutations are largely unknown.

Purpose of the Study:

• To investigate the contribution of four specific missense LKB1 somatic mutations to tumor biology.
• To elucidate the functional consequences of these LKB1 alterations in cancer development.

Main Methods:

• Analysis of tumor suppressor capabilities and kinase activity of LKB1 mutants.
• Assessment of cell motility and gene expression changes induced by LKB1 mutations.
• Comparative secretome analysis to identify protein networks associated with LKB1 alterations.

Main Results:

• Three out of four LKB1 mutants lost tumor suppressor function and kinase activity.
• One LKB1 mutant retained enzymatic activity but increased cell motility.
• Mutant LKB1 isoforms differentially regulated genes involved in vesicle trafficking, cell adhesion, and cytokine production, promoting tumor growth and inflammation-like features.

Conclusions:

• Somatic LKB1 missense mutations can acquire oncogenic roles, contributing to cancer progression.
• These findings expand the understanding of LKB1's involvement in cancer beyond its canonical tumor suppressor function.
• Identifying oncogenic roles of LKB1 mutations aids in comprehending cancer development and progression.